Suzhou Industrial Park Heshun Electric
300141
Guangdong Xiongsu Technology Group
300599
Sichuan Chuanhuan Technology
300547
Shanghai Wisdom Information Technology
301315
KANGNONG SEED
837403
CN Stock MarketDetailed Quotes
000403 Pacific Shuanglin Bio-pharmacy
- 21.39
- +0.14+0.66%
Market Closed Dec 27 15:00 CST
15.64BMarket Cap18.88P/E (TTM)
21.52High21.06Low48.56KlotVolume21.25Open21.25Pre Close103.49MTurnover0.71%Turnover Ratio25.56P/E (Static)731.07MShares30.2952wk High2.04P/B14.65BFloat Cap19.3152wk Low23.38Limit Up684.71MShs Float49.82Historical High19.13Limit Down2.17%Amplitude0.51Historical Low0.35Dividend TTM21.31Avg Price25.58KlotAsk1.64%Div YieldTTM100Lot Size21.74KlotBid
Pacific Shuanglin Bio-pharmacy Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 37.49%1.89B | 60.23%1.14B | 67.00%435.64M | -3.18%2.33B | -7.95%1.37B | -28.45%709.07M | -47.87%260.86M | 21.98%2.41B | 11.27%1.49B | 25.35%991.05M |
| Operating revenue | 37.49%1.89B | 60.23%1.14B | 67.00%435.64M | -3.18%2.33B | -7.95%1.37B | -28.45%709.07M | -47.87%260.86M | 21.98%2.41B | 11.27%1.49B | 25.35%991.05M |
| Other operating revenue | ---- | -74.34%639.45K | ---- | -65.97%3.27M | ---- | 335.96%2.49M | ---- | 82.15%9.59M | ---- | 246.63%571.6K |
| Total operating cost | 23.84%1.28B | 34.90%772.12M | 36.27%297.49M | -6.49%1.64B | -6.64%1.03B | -22.60%572.35M | -43.22%218.31M | 17.88%1.75B | 11.09%1.11B | 24.83%739.46M |
| Operating cost | 36.21%935.38M | 55.70%565.85M | 57.26%211.64M | -1.87%1.13B | -8.63%686.74M | -30.32%363.42M | -50.55%134.58M | 8.29%1.15B | 6.50%751.61M | 23.14%521.57M |
| Operating tax surcharges | 32.01%15.46M | 42.75%9.47M | 61.35%4.54M | 29.15%21.69M | 10.16%11.71M | -6.43%6.63M | -27.56%2.81M | 9.93%16.8M | 2.49%10.63M | 12.40%7.09M |
| Operating expense | -6.71%188.69M | -14.89%102.99M | -18.05%33.96M | -28.53%285.57M | -7.01%202.26M | -5.81%121.01M | -40.66%41.43M | 74.28%399.57M | 41.68%217.51M | 56.60%128.47M |
| Administration expense | 7.75%131.08M | 4.70%85.13M | 2.78%39.94M | 8.93%180.25M | -0.08%121.65M | -1.63%81.31M | 6.04%38.86M | -12.78%165.48M | -11.25%121.75M | -0.74%82.65M |
| Financial expense | 13.78%-36.95M | 15.10%-24.95M | 1.42%-13.46M | -4.08%-57.57M | -10.24%-42.85M | -14.82%-29.39M | -8.11%-13.65M | -20.83%-55.31M | -13.42%-38.87M | -24.73%-25.6M |
| -Interest expense (Financial expense) | 24.02%7.68M | 22.50%5.48M | -18.25%2.01M | -19.96%9.63M | -24.14%6.2M | -21.33%4.47M | -8.83%2.46M | 11.60%12.03M | -14.43%8.17M | -31.46%5.69M |
| -Interest Income (Financial expense) | 10.67%-44.95M | 9.92%-30.7M | 4.55%-15.69M | -3.84%-67.68M | -3.00%-50.32M | -7.24%-34.08M | -6.25%-16.44M | -11.24%-65.18M | -11.43%-48.85M | -10.10%-31.78M |
| Research and development | -14.48%45.98M | 14.52%33.64M | 46.17%20.86M | 5.73%79.69M | 21.84%53.76M | 16.25%29.37M | -2.06%14.27M | 111.52%75.36M | 85.63%44.12M | 42.39%25.27M |
| Credit Impairment Loss | -64.56%2.86M | -79.15%1.87M | -88.05%1.44M | 127.17%3.21M | 291.92%8.07M | 310.76%8.97M | 2,764.23%12.06M | -25.20%-11.82M | 33.48%-4.2M | -31.64%-4.26M |
| Asset Impairment Loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 100.12%124.41K | ---- | ---- |
| Other net revenue | -9.54%28.13M | -25.16%18.44M | -46.86%10.96M | -48.51%5.96M | 170.58%31.09M | 1,334.39%24.64M | 397.92%20.62M | 148.49%11.58M | 109.73%11.49M | -62.99%1.72M |
| Fair value change income | -218.38%-10.59M | -342.28%-13.7M | -254.95%-4.24M | -484.85%-18.97M | 217.43%8.95M | 1,546.93%5.66M | 87.47%2.74M | -93.36%4.93M | --2.82M | --343.43K |
| Invest income | 574.51%29.39M | 839.73%24.37M | 1,301.96%8.65M | 143.66%7.4M | 65.46%4.36M | 62.56%2.59M | -44.95%616.69K | -17.92%3.04M | -47.87%2.63M | -41.76%1.6M |
| Asset deal income | 382.99%58.07K | 5,588.70%683.96K | 110,562.94%595.4K | -224.40%-544.96K | -97.25%12.02K | 237.07%12.02K | -85.90%538.03 | 64.53%438.08K | 890.65%437.78K | -109.78%-8.77K |
| Other revenue | -33.96%6.41M | -29.62%5.21M | -13.31%4.52M | -0.01%14.86M | -0.95%9.71M | 83.24%7.41M | 158.96%5.21M | 34.24%14.86M | 46.30%9.8M | -19.86%4.04M |
| Operating profit | 71.41%638.75M | 137.04%382.5M | 136.04%149.11M | 4.79%695.19M | -6.42%372.64M | -36.30%161.36M | -47.40%63.17M | 44.09%663.43M | 13.33%398.21M | 24.86%253.31M |
| Add:Non operating Income | -96.77%105.9K | -90.82%98.68K | 56,550.50%107.88K | 40.42%3.53M | 2,240.22%3.28M | 668.70%1.08M | 15,509.02%190.43 | 369.58%2.52M | 198.87%140.3K | 275.39%139.86K |
| Less:Non operating expense | 230.11%19.31M | 277.66%11.74M | 3,121.51%8.27M | 91.09%10.61M | 221.78%5.85M | 109.80%3.11M | -77.22%256.78K | 88.10%5.55M | 262.82%1.82M | 336.78%1.48M |
| Total profit | 67.41%619.55M | 132.76%370.85M | 124.03%140.95M | 4.20%688.11M | -6.67%370.07M | -36.77%159.33M | -47.12%62.92M | 44.19%660.39M | 12.99%396.54M | 24.38%251.97M |
| Less:Income tax cost | 73.51%76.79M | 168.72%43.88M | 184.83%19.08M | 5.41%76.64M | -3.77%44.26M | -46.25%16.33M | -48.36%6.7M | 9.37%72.7M | -1.20%45.99M | 15.89%30.38M |
| Net profit | 66.59%542.76M | 128.65%326.98M | 116.78%121.87M | 4.05%611.47M | -7.06%325.81M | -35.47%143M | -46.97%56.22M | 50.10%587.69M | 15.16%350.55M | 25.64%221.59M |
| Net profit from continuing operation | 66.59%542.76M | 128.65%326.98M | 116.78%121.87M | 4.05%611.47M | -7.06%325.81M | -35.47%143M | -46.97%56.22M | 50.10%587.69M | 15.16%350.55M | 25.64%221.59M |
| Less:Minority Profit | 106.68%25.52K | 93.69%-8.59K | 50.02%-78.85K | -214.31%-638.57K | -138.00%-382.1K | -123.26%-136.17K | -139.51%-157.77K | 17.35%558.65K | 110.10%1.01M | 43.67%585.52K |
| Net profit of parent company owners | 66.38%542.73M | 128.44%326.98M | 116.31%121.95M | 4.25%612.11M | -6.68%326.2M | -35.23%143.14M | -46.62%56.38M | 50.14%587.13M | 15.01%349.54M | 25.60%221.01M |
| Earning per share | ||||||||||
| Basic earning per share | 66.48%0.7425 | 128.50%0.4474 | 116.47%0.1669 | 4.34%0.8384 | -6.77%0.446 | -35.29%0.1958 | -46.68%0.0771 | 44.96%0.8035 | 9.90%0.4784 | 17.29%0.3026 |
| Diluted earning per share | 66.48%0.7425 | 128.50%0.4474 | 116.47%0.1669 | 4.38%0.8384 | -6.69%0.446 | -35.25%0.1958 | -46.61%0.0771 | 45.24%0.8032 | 10.09%0.478 | 17.48%0.3024 |
| Other composite income | -126.87%-5.64K | -86.47%3.46K | 111.10%1.01K | -69.03%11.04K | -72.62%20.99K | 154.34%25.57K | -254.99%-9.14K | 36,365.92%35.64K | 76.65K | 10.05K |
| Other composite income of parent company owners | -126.87%-5.64K | -86.47%3.46K | 111.10%1.01K | -69.03%11.04K | -72.62%20.99K | 154.34%25.57K | -254.99%-9.14K | 36,365.92%35.64K | --76.65K | --10.05K |
| Total composite income | 66.57%542.75M | 128.61%326.98M | 116.82%121.87M | 4.04%611.48M | -7.07%325.83M | -35.46%143.03M | -46.98%56.21M | 50.11%587.73M | 15.19%350.62M | 25.65%221.6M |
| Total composite income of parent company owners | 66.37%542.73M | 128.40%326.99M | 116.35%121.95M | 4.25%612.12M | -6.69%326.22M | -35.23%143.16M | -46.63%56.37M | 50.15%587.17M | 15.04%349.62M | 25.61%221.02M |
| Total composite income of minority owners | 106.68%25.52K | 93.69%-8.59K | 50.02%-78.85K | -214.31%-638.57K | -138.00%-382.1K | -123.26%-136.17K | -139.51%-157.77K | 17.35%558.65K | 110.10%1.01M | 43.67%585.52K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
